This study is in progress, not accepting new patients
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
Summary
- Eligibility
- for people ages 25 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- PTC Therapeutics
- ID
- NCT05358717
- Phase
- Phase 2 Huntington's Disease Research Study
- Study Type
- Interventional
- Participants
- Expecting 252 study participants
- Last Updated